Safety, tolerability, and efficacy of atogepant added to onabotulinumtoxinA for the preventive treatment of chronic migraine: A phase 3, multicenter, 24-week, open-label study.
Saved in:
| Title: | Safety, tolerability, and efficacy of atogepant added to onabotulinumtoxinA for the preventive treatment of chronic migraine: A phase 3, multicenter, 24-week, open-label study. |
|---|---|
| Authors: | Rothrock, John1 (AUTHOR) rothrockjf@gmail.com, Najib, Umer2 (AUTHOR), Ailani, Jessica3 (AUTHOR), Ashina, Sait4 (AUTHOR), Bao, Jia5 (AUTHOR), Smith, Jonathan H.5 (AUTHOR), Adams, Aubrey M.5 (AUTHOR), Dabruzzo, Brett5 (AUTHOR), Pfleeger, Kimberly5 (AUTHOR), Blumenfeld, Andrew6 (AUTHOR) |
| Source: | Cephalalgia. Apr2026, Vol. 46 Issue 4, p1-12. 12p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 03331024 |
|---|---|
| DOI: | 10.1177/03331024261429118 |
